Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1988 Jul;51(7):920–923. doi: 10.1136/jnnp.51.7.920

Botulinum toxin in spasmodic torticollis.

R Stell 1, P D Thompson 1, C D Marsden 1
PMCID: PMC1033194  PMID: 3204400

Abstract

Ten patients with spasmodic torticollis were treated by injection of a total dose of 30 ng of botulinum toxin type A into the affected sternomastoid and posterior cervical muscles. Nine patients reported improvement in head position and control, which was confirmed in seven cases by clinical assessment and "blind" videotape ratings before and 6 weeks after injection. Five patients who had pain reported relief. Seven patients had mild transient dysphagia after injection; two who were given a more concentrated solution of the toxin developed more severe dysphagia, but this also recovered. Other minor transient side effects included weakness of the voice and local pain. The beneficial effects of botulinum toxin injections lasted some 2 to 3 months. A slight reduction in the total dose of toxin injected avoided the main side effects, and this method of treatment appears to offer successful control of head position and pain in the majority of patients with torticollis.

Full text

PDF
923

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrew J., Fowler C. J., Harrison M. J. Stereotaxic thalamotomy in 55 cases of dystonia. Brain. 1983 Dec;106(Pt 4):981–1000. doi: 10.1093/brain/106.4.981. [DOI] [PubMed] [Google Scholar]
  2. Bertrand C. M., Molina-Negro P. Selective peripheral denervation in 111 cases of spasmodic torticollis: rationale and results. Adv Neurol. 1988;50:637–643. [PubMed] [Google Scholar]
  3. Black J. D., Dolly J. O. Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. I. Ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves. J Cell Biol. 1986 Aug;103(2):521–534. doi: 10.1083/jcb.103.2.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brierley H. The treatment of hysterical spasmodic torticollis by behaviour therapy. Behav Res Ther. 1967 May;5(2):139–142. doi: 10.1016/0005-7967(67)90011-3. [DOI] [PubMed] [Google Scholar]
  5. Brudny J., Grynbaum B. B., Korein J. Spasmodic torticollis: treatment by feedback display of the EMG. Arch Phys Med Rehabil. 1974 Sep;55(9):403–408. [PubMed] [Google Scholar]
  6. Cooper I. S. Neurosurgical treatment of the dyskinesias. Clin Neurosurg. 1977;24:367–390. doi: 10.1093/neurosurgery/24.cn_suppl_1.367. [DOI] [PubMed] [Google Scholar]
  7. Elston J. S., Russell R. W. Effect of treatment with botulinum toxin on neurogenic blepharospasm. Br Med J (Clin Res Ed) 1985 Jun 22;290(6485):1857–1859. doi: 10.1136/bmj.290.6485.1857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jankovic J., Orman J. Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study. Neurology. 1987 Apr;37(4):616–623. doi: 10.1212/wnl.37.4.616. [DOI] [PubMed] [Google Scholar]
  9. Kao I., Drachman D. B., Price D. L. Botulinum toxin: mechanism of presynaptic blockade. Science. 1976 Sep 24;193(4259):1256–1258. doi: 10.1126/science.785600. [DOI] [PubMed] [Google Scholar]
  10. Mauriello J. A., Jr Blepharospasm, Meige syndrome, and hemifacial spasm: treatment with botulinum toxin. Neurology. 1985 Oct;35(10):1499–1500. doi: 10.1212/wnl.35.10.1499. [DOI] [PubMed] [Google Scholar]
  11. Scott A. B. Botulinum toxin injection of eye muscles to correct strabismus. Trans Am Ophthalmol Soc. 1981;79:734–770. [PMC free article] [PubMed] [Google Scholar]
  12. Scott A. B., Kennedy R. A., Stubbs H. A. Botulinum A toxin injection as a treatment for blepharospasm. Arch Ophthalmol. 1985 Mar;103(3):347–350. doi: 10.1001/archopht.1985.01050030043017. [DOI] [PubMed] [Google Scholar]
  13. Tsui J. K., Eisen A., Stoessl A. J., Calne S., Calne D. B. Double-blind study of botulinum toxin in spasmodic torticollis. Lancet. 1986 Aug 2;2(8501):245–247. doi: 10.1016/s0140-6736(86)92070-2. [DOI] [PubMed] [Google Scholar]
  14. Wiegand H., Erdmann G., Wellhöner H. H. 125I-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection. Naunyn Schmiedebergs Arch Pharmacol. 1976;292(2):161–165. doi: 10.1007/BF00498587. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES